LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.031623
 46.95 84.90 1525 4952 0.3079 0.6362
MN20160318_Q02
H17
MCF 10A-H2B-mCherry Neratinib
0.031623
 46.95 84.90 419 4952 0.0846 0.3128
MN20160318_Q02
I20
MCF 10A-H2B-mCherry Neratinib
0.031623
 46.95 84.90 4230 4952 0.8541 0.9470
MN20160318_Q02
I20
MCF 10A-H2B-mCherry Neratinib
0.031623
 48.65 84.90 1 5328 0.0002 -0.5247
MN20160318_Q02
H17
MCF 10A-H2B-mCherry Neratinib
0.031623
 48.65 84.90 1666 5328 0.3126 0.6462
MN20160318_Q02
H17
MCF 10A-H2B-mCherry Neratinib
0.031623
 48.65 84.90 455 5328 0.0854 0.3246
MN20160318_Q02
I20
MCF 10A-H2B-mCherry Neratinib
0.031623
 48.65 84.90 4500 5328 0.8445 0.9442
MN20160318_Q02
I20
MCF 10A-H2B-mCherry Neratinib
0.031623
 50.36 84.90 1 5651 0.0002 -0.5197
MN20160318_Q02
H17
MCF 10A-H2B-mCherry Neratinib
0.031623
 50.36 84.90 1866 5651 0.3302 0.6656
MN20160318_Q02
H17
MCF 10A-H2B-mCherry Neratinib
0.031623
 50.36 84.90 511 5651 0.0904 0.3450
MN20160318_Q02
I20
MCF 10A-H2B-mCherry Neratinib
0.031623
 50.36 84.90 4708 5651 0.8331 0.9406
MN20160318_Q02
I20
MCF 10A-H2B-mCherry Neratinib
0.031623
 52.06 84.90 2 5990 0.0003 -0.4569
MN20160318_Q02
H17
MCF 10A-H2B-mCherry Neratinib
0.031623
 52.06 84.90 2100 5990 0.3505 0.6861
MN20160318_Q02
H17
MCF 10A-H2B-mCherry Neratinib
0.031623
 52.06 84.90 537 5990 0.0896 0.3504
MN20160318_Q02
I20
MCF 10A-H2B-mCherry Neratinib
0.031623
 52.06 84.90 4960 5990 0.8279 0.9394
MN20160318_Q02
I20
MCF 10A-H2B-mCherry Neratinib
0.031623
 53.77 84.90 4 6252 0.0006 -0.3889
MN20160318_Q02
H17
MCF 10A-H2B-mCherry Neratinib
0.031623
 53.77 84.90 2219 6252 0.3549 0.6924
MN20160318_Q02
H17
MCF 10A-H2B-mCherry Neratinib
0.031623
 53.77 84.90 587 6252 0.0939 0.3658
MN20160318_Q02
I20
MCF 10A-H2B-mCherry Neratinib
0.031623
 53.77 84.90 5261 6252 0.8414 0.9451
MN20160318_Q02
I20
MCF 10A-H2B-mCherry Neratinib
0.031623
 55.48 84.90 3 6567 0.0005 -0.4131
MN20160318_Q02
H17
MCF 10A-H2B-mCherry Neratinib
0.031623
 55.48 84.90 2406 6567 0.3663 0.7042
MN20160318_Q02
H17
MCF 10A-H2B-mCherry Neratinib
0.031623
 55.48 84.90 680 6567 0.1035 0.3933
MN20160318_Q02
I20
MCF 10A-H2B-mCherry Neratinib
0.031623
 55.48 84.90 5641 6567 0.8589 0.9521
MN20160318_Q02
I20
MCF 10A-H2B-mCherry Neratinib
0.031623
 57.18 84.90 5 6963 0.0007 -0.3595
MN20160318_Q02
H17
MCF 10A-H2B-mCherry Neratinib
0.031623
 57.18 84.90 2783 6963 0.3997 0.7313
MN20160318_Q02
H17